Roeland Vandebrouck

Distribution Network Director
AstraZeneca

In order to develop and future-proof the AstraZeneca distribution network in Europe, Middle East and Africa , Roeland is responsible for distribution network strategy and management. Recently he led the integration of acquired diabetes and respiratory portfolios in AstraZeneca’s distribution network. Roeland is a member of the company’s Global Distribution Network, leveraging the capability of a global network to drive value through the end-to-end supply chain.

Check out the incredible speaker line-up to see who will be joining Roeland.

Download The Latest Agenda

Wednesday 15th April 2015 - Main Conference Day One

Friday, March 4th, 2016

14:20 COMMUNITY FORUM: How should you choose the most effective channel in new markets to provide the best quality of service to the customer: Wholesalers vs. distributors vs. direct to patients?

Determining what criteria for channels should be considered when moving into new markets
What are the pros and cons of each channel strategy?
What are the benefits and risks of going to wholesalers vs. distributors vs. direct to patients?
Implementing key performance indicators (KPIs) to bring the right quality of service to the customer